CorMedix (CRMD) Short-term Investments (2015 - 2025)

CorMedix has disclosed Short-term Investments across 10 years of filings, most recently posting $10.4 million for Q4 2025.

• Short-term Investments for Q4 2025 came in at $10.4 million, down 6.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.4 million (down 6.1% YoY), and the FY2025 annual result was $10.4 million, down 6.1% from the prior year.
• Short-term Investments came in at $10.4 million for Q4 2025 at CorMedix, up from $7.2 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $33.3 million in Q3 2023 to a low of $77453.0 in Q4 2023.
• The 5-year median for Short-term Investments is $10.6 million (2024), against an average of $11.2 million.
• Across the five-year window, Short-term Investments slumped 98.76% in 2021 and soared 19511.96% in 2024, its largest moves.
• CorMedix's Short-term Investments stood at $131567.0 in 2021, then declined by 5.67% to $124102.0 in 2022, then tumbled by 37.59% to $77453.0 in 2023, then soared by 14149.93% to $11.0 million in 2024, then retreated by 6.1% to $10.4 million in 2025.
• The last three Short-term Investments figures came in at $10.4 million (Q4 2025), $7.2 million (Q3 2025), and $31.4 million (Q2 2025), per Business Quant data.